Literature DB >> 18684087

Dynamic and structural properties of the skeleton in hypoparathyroidism.

Mishaela R Rubin1, David W Dempster, Hua Zhou, Elizabeth Shane, Thomas Nickolas, James Sliney, Shonni J Silverberg, John P Bilezikian.   

Abstract

Hypoparathyroidism, a disorder in which PTH is absent, is associated with BMD that is above average. We studied associated structural and dynamic properties of the skeleton in hypoparathyroidism. Thirty-three subjects with hypoparathyroidism and 33 age- and sex-matched control subjects with no known metabolic diseases underwent percutaneous iliac crest bone biopsies after double-labeling with tetracycline. The main outcome was histomorphometric assessment of structural and dynamic skeletal parameters. Subjects with hypoparathyroidism had greater cancellous bone volume (mean +/- SD; BV/TV: 23.5 +/- 8 versus 19.7 +/- 5%, p = 0.02), trabecular width (Tb.Wi: 136.1 +/- 37 versus 119.3 +/- 21 microm, p = 0.03), and cortical width (Ct.Wi: 923.4 +/- 420 versus 753.5 +/- 246 microm, p = 0.05) than control subjects. Dynamic skeletal indices, including mineralizing surface (MS: 0.85 +/- 1.58 versus 4.27 +/- 3.32%, p < 0.0001) and bone formation rate (BFR/BS: 0.006 +/- 0.014 versus 0.032 +/- 0.028 microm(3)/microm(2)/d, p < 0.0001), were profoundly suppressed in the hypoparathyroid subjects. We conclude that hypoparathyroidism is characterized by markedly unusual structural and dynamic properties of bone.

Entities:  

Mesh:

Year:  2008        PMID: 18684087      PMCID: PMC2686925          DOI: 10.1359/jbmr.080803

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  39 in total

Review 1.  How well are bones designed to resist fracture?

Authors:  John D Currey
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

2.  Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.

Authors:  M Sääf; A Hilding; M Thorën; S Troell; K Hall
Journal:  Eur J Endocrinol       Date:  1999-05       Impact factor: 6.664

Review 3.  Bone microarchitecture and strength.

Authors:  David W Dempster
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 4.  Microdamage and bone strength.

Authors:  David Burr
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

5.  Osteoblast-derived PTHrP is a physiological regulator of bone formation.

Authors:  T John Martin
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

6.  Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.

Authors:  Dengshun Miao; Bin He; Yebin Jiang; Tatsuya Kobayashi; Maria A Sorocéanu; Jenny Zhao; Hanyi Su; Xinkang Tong; Norio Amizuka; Ajay Gupta; Harry K Genant; Henry M Kronenberg; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

7.  On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.

Authors:  D W Dempster; M Parisien; S J Silverberg; X G Liang; M Schnitzer; V Shen; E Shane; D B Kimmel; R Recker; R Lindsay; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

8.  A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism.

Authors:  T Sunthornthepvarakul; S Churesigaew; S Ngowngarmratana
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 9.  The 22q11 deletion syndromes.

Authors:  P J Scambler
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

10.  Parathyroid function and growth in 22q11.2 deletion syndrome.

Authors:  Raja Brauner; Agnes Le Harivel de Gonneville; Catherine Kindermans; Jérone Le Bidois; Marguerite Prieur; Stanislaus Lyonnet; Jean-Claude Souberbielle
Journal:  J Pediatr       Date:  2003-05       Impact factor: 4.406

View more
  48 in total

Review 1.  Mini-review: new therapeutic options in hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; James Sliney; John P Bilezikian
Journal:  Endocrine       Date:  2012-02-07       Impact factor: 3.633

2.  Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.

Authors:  K Amrein; H P Dimai; H Dobnig; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

Review 3.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

4.  Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys.

Authors:  Masaru Shimizu; Eri Joyashiki; Hiroshi Noda; Tomoyuki Watanabe; Makoto Okazaki; Miho Nagayasu; Kenji Adachi; Tatsuya Tamura; John T Potts; Thomas J Gardella; Yoshiki Kawabe
Journal:  J Bone Miner Res       Date:  2016-05-23       Impact factor: 6.741

Review 5.  Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.

Authors:  R Pal; S K Bhadada; S Mukherjee; M Banerjee; A Kumar
Journal:  Osteoporos Int       Date:  2021-05-22       Impact factor: 4.507

6.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 7.  Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.

Authors:  Esther S Kim; Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

8.  Parathyroid hormone therapy for hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; John P Bilezikian
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2014-09-10       Impact factor: 4.690

9.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

Review 10.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.